|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Fair value of common stock issued in exchange for services | |||||
| Fair value of options issued in exchange for services | |||||
| Depreciation and amortization | |||||
| Amortization | |||||
| Forgiveness of debt | |||||
| Decrease in assets | |||||
| Prepaid expenses | |||||
| Increase in liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable and accrued expenses - related parties | |||||
| Common stock to be issued | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Investment in patents | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Exercise of options | |||||
| Proceeds from sale of 10% secured convertible notes payable - stockholders | |||||
| Repayment of notes payable - stockholders | |||||
| Proceeds from sale of Series B Preferred Stock | |||||
| Net cash provided by financing activities | |||||
| DECREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS - END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES: | |||||
| Elimination of noncontrolling interests upon dissolution | |||||
| Conversion of Series A Preferred Stock to common stock | |||||
| Conversion of 10% secured convertible note payable and accrued interest into 5,399 shares of Series B Preferred Stock | |||||
| Conversion of 10% secured convertible note payable and accrued interest into 3,383 and 5,399 shares of Series B Preferred Stock | |||||
Loading...